Theravance Biopharma Current Ratio 2012-2020 | TBPH

Theravance Biopharma current ratio from 2012 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Theravance Biopharma Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.53B $0.10B 5.45
2019-12-31 $0.34B $0.11B 3.03
2019-09-30 $0.36B $0.11B 3.27
2019-06-30 $0.43B $0.11B 3.87
2019-03-31 $0.47B $0.11B 4.12
2018-12-31 $0.53B $0.10B 5.41
2018-09-30 $0.33B $0.10B 3.26
2018-06-30 $0.39B $0.09B 4.14
2018-03-31 $0.45B $0.11B 4.25
2017-12-31 $0.38B $0.06B 6.06
2017-09-30 $0.37B $0.05B 7.53
2017-06-30 $0.39B $0.06B 6.74
2017-03-31 $0.42B $0.05B 8.61
2016-12-31 $0.53B $0.05B 10.73
2016-09-30 $0.27B $0.05B 6.04
2016-06-30 $0.30B $0.05B 6.79
2016-03-31 $0.24B $0.05B 5.15
2015-12-31 $0.24B $0.05B 4.80
2015-09-30 $0.24B $0.03B 8.69
2015-06-30 $0.26B $0.02B 10.63
2015-03-31 $0.28B $0.03B 9.55
2014-12-31 $0.28B $0.04B 6.68
2014-09-30 $0.31B $0.04B 8.56
2014-06-30 $0.38B $0.04B 9.54
2014-03-31 $0.02B $0.04B 0.41
2013-12-31 $0.01B $0.04B 0.38
2013-09-30 $0.00B 0.00
2013-06-30 $0.00B 0.00
2013-03-31 $0.00B 0.00
2012-12-31 $0.01B $0.02B 0.48
2011-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.090B $0.073B
Theravance Biopharma, Inc. is a biopharmaceutical company. It is focused on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including bacterial infections, central nervous system (CNS)/pain, respiratory disease, and gastrointestinal (GI) motility dysfunction. Theravance Biopharma, Inc. is based in George Town, Cayman Islands.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $74.564B 42.41
Takeda Pharmaceutical (TAK) Japan $58.294B 10.16
Astellas Pharma (ALPMY) Japan $29.965B 15.18
Eisai (ESALY) Japan $27.403B 23.16
UCB SA (UCBJF) Belgium $23.720B 0.00
Merck (MKGAF) Germany $17.131B 22.47
Catalent (CTLT) United States $13.151B 50.84
Grifols, S.A (GRFS) Spain $12.369B 15.12
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $10.539B 40.80
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $7.463B 47.27
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $7.052B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.803B 11.25
United Therapeutics (UTHR) United States $4.848B 11.21
Arrowhead Pharmaceuticals (ARWR) United States $4.151B 0.00
Evotec AG (EVTCY) Germany $4.113B 110.84
FibroGen (FGEN) United States $4.069B 0.00
Hypermarcas (HYPMY) Brazil $3.887B 14.30
ChemoCentryx (CCXI) United States $3.697B 0.00
Nektar Therapeutics (NKTR) United States $3.650B 0.00
PTC Therapeutics (PTCT) United States $3.250B 0.00
Sage Therapeutics (SAGE) United States $2.670B 0.00
Pacira BioSciences (PCRX) United States $2.563B 67.37
Taro Pharmaceutical Industries (TARO) Israel $2.442B 11.82
Cronos Group (CRON) Canada $1.942B 0.00
Revolution Medicines (RVMD) United States $1.848B 0.00
Xencor (XNCR) United States $1.832B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.765B 0.00
USANA Health Sciences (USNA) United States $1.741B 16.40
Indivior (INVVY) United States $1.614B 20.00
Ironwood Pharmaceuticals (IRWD) United States $1.583B 11.03
Corcept Therapeutics (CORT) United States $1.561B 14.37
Akebia Therapeutics (AKBA) United States $1.473B 0.00
Heron Therapeutics (HRTX) United States $1.413B 0.00
Zogenix (ZGNX) United States $1.372B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.264B 12.06
VAXART, INC (VXRT) United States $1.174B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.102B 0.00
Karyopharm Therapeutics (KPTI) United States $1.078B 0.00
Translate Bio (TBIO) United States $1.056B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.951B 592.13
Esperion Therapeutics (ESPR) United States $0.932B 0.00
Tilray (TLRY) Canada $0.865B 0.00
Altimmune (ALT) United States $0.739B 0.00
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
Endo (ENDP) Ireland $0.729B 1.08
Trillium Therapeutics (TRIL) Canada $0.705B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.699B 0.00
ImmunoGen (IMGN) United States $0.672B 0.00
Collegium Pharmaceutical (COLL) United States $0.653B 0.00
Molecular Templates (MTEM) United States $0.599B 0.00
Flexion Therapeutics (FLXN) United States $0.597B 0.00
Radius Health (RDUS) United States $0.574B 0.00
Aerie Pharmaceuticals (AERI) United States $0.572B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.569B 0.00
Siga Technologies (SIGA) United States $0.554B 59.08
Crinetics Pharmaceuticals (CRNX) United States $0.516B 0.00
Ocular Therapeutix (OCUL) United States $0.510B 0.00
Innate Pharma SA (IPHYF) France $0.506B 0.00
Ardelyx (ARDX) United States $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.468B 23.36
DURECT (DRRX) United States $0.461B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.429B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.429B 0.00
Organogenesis Holdings (ORGO) United States $0.427B 0.00
TherapeuticsMD (TXMD) United States $0.422B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.346B 8.56
Harpoon Therapeutics (HARP) United States $0.344B 0.00
IMV INC (IMV) Canada $0.335B 0.00
Redhill Biopharma (RDHL) Israel $0.316B 0.00
Heat Biologics (HTBX) United States $0.316B 0.00
Concert Pharmaceuticals (CNCE) United States $0.299B 0.00
OptiNose (OPTN) United States $0.298B 0.00
MEI Pharma (MEIP) United States $0.296B 0.00
Calithera Biosciences (CALA) United States $0.293B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.290B 0.00
Rafael Holdings (RFL) United States $0.285B 0.00
PROFOUND MEDICL (PROF) Canada $0.279B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.275B 0.00
Lannett Co Inc (LCI) United States $0.249B 5.45
CASI Pharmaceuticals (CASI) United States $0.240B 0.00
Aquestive Therapeutics (AQST) United States $0.222B 0.00
Nature's Sunshine Products (NATR) United States $0.216B 21.33
KalVista Pharmaceuticals (KALV) United States $0.204B 0.00
Taiwan Liposome (TLC) Taiwan $0.194B 0.00
Nivalis Therapeutics (ALPN) United States $0.189B 0.00
Onconova Therapeutics (ONTX) United States $0.186B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.170B 0.00
Jounce Therapeutics (JNCE) United States $0.163B 7.69
Xeris Pharmaceuticals (XERS) United States $0.124B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.122B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.114B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.110B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Otonomy (OTIC) United States $0.103B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.102B 0.00
Lipocine (LPCN) United States $0.102B 0.00
Biomerica (BMRA) United States $0.101B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.098B 0.00
MediWound (MDWD) Israel $0.097B 0.00
Aclaris Therapeutics (ACRS) United States $0.097B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.094B 0.00
CTI BioPharma (CTIC) United States $0.094B 0.00
Hemispherx BioPharma (AIM) United States $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.090B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.084B 0.00
Addex Therapeutics (ADXN) Switzerland $0.079B 0.00
ElectroCore (ECOR) United States $0.076B 0.00
Recro Pharma (REPH) United States $0.076B 0.00
SCYNEXIS (SCYX) United States $0.072B 0.00
Infinity Pharmaceuticals (INFI) United States $0.069B 0.00
CV Sciences (CVSI) United States $0.067B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.065B 0.00
GTx (ONCT) United States $0.060B 0.00
Sundial Growers (SNDL) Canada $0.058B 0.00
PolarityTE (PTE) United States $0.056B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.73
Novan (NOVN) United States $0.049B 0.00
AgeX Therapeutics (AGE) United States $0.049B 0.00
Natural Alternatives (NAII) United States $0.047B 0.00
IsoRay (ISR) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
Jaguar Animal Health (JAGX) United States $0.043B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.042B 9.36
Opiant Pharmaceuticals (OPNT) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.036B 0.00
Neos Therapeutics (NEOS) United States $0.035B 0.00
Can-Fite Biopharma (CANF) Israel $0.033B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.031B 0.00
ProPhase Labs (PRPH) United States $0.030B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.030B 0.00
India Globalization Capital (IGC) United States $0.026B 0.00
Vical (BBI) United States $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
RXi Pharmaceuticals (PHIO) United States $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 21.36
Shineco (TYHT) China $0.014B 0.00
China SXT Pharmaceuticals (SXTC) China $0.013B 0.00
Midatech Pharma (MTP) United Kingdom $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00